Question 1

How does Euphorbia peplus work to remove warts and treat skin cancer?

Accepted Answer

Euphorbia peplus contains ingenol mebutate and phorbol esters that work through dual mechanisms. These compounds induce rapid cell death (necrosis) in abnormal skin cells within hours of application, then trigger a sustained immune response through neutrophil-mediated inflammation. Ingenol mebutate disrupts cellular mitochondria and plasma membranes while activating protein kinase C pathways. This two-phase action destroys visible lesions and stimulates the immune system to clear remaining abnormal cells. Evidence Level: C.

Question 2

Does Euphorbia peplus interact with any medications?

Accepted Answer

There are no well-documented systemic drug interactions with Euphorbia peplus when used topically, as the active compounds are not intended for systemic circulation. However, concurrent use with other topical skin treatments, immunosuppressant medications, or photosensitizing drugs has not been adequately studied. Patients using prescription medications for skin conditions should consult a healthcare provider before combining treatments. The latex must never contact broken skin or mucous membranes, as this could increase systemic absorption and toxicity risk. Evidence Level: Traditional/insufficient data.

Question 3

What is the correct dosage of Euphorbia peplus latex for wart removal?

Accepted Answer

Traditional use involves applying a tiny amount of fresh plant latex directly to the wart using a toothpick or cotton swab, carefully avoiding contact with surrounding healthy skin. Application typically occurs once daily or every few days until the lesion resolves. Commercial ingenol mebutate gel follows specific protocols: one application for actinic keratosis or two consecutive daily applications for basal cell carcinoma. Self-treatment with raw plant material carries risks of variable potency and severe skin reactions. Medical supervision is strongly advised. Evidence Level: C.

Question 4

Is Euphorbia peplus safe to use during pregnancy or breastfeeding?

Accepted Answer

Euphorbia peplus is unsafe during pregnancy and breastfeeding. The diterpene esters, including ingenol mebutate, are cytotoxic compounds that can cause systemic toxicity if absorbed through skin. While intact skin limits absorption, accidental application to damaged skin or mucous membranes could allow these compounds to enter circulation. Animal studies on similar diterpenes suggest potential for fetal harm. Pregnant or breastfeeding individuals should avoid all contact with Euphorbia peplus latex and products containing its active constituents. Evidence Level: C/Traditional contraindication.

Question 5

Can Euphorbia peplus effectively treat actinic keratosis and skin cancer?

Accepted Answer

Yes, Euphorbia peplus has demonstrated effectiveness for treating actinic keratosis and superficial basal cell carcinoma. The pharmaceutical preparation ingenol mebutate received regulatory approval based on clinical trials showing clearance rates for actinic keratosis lesions. Traditional use of raw plant latex for skin lesions spans millennia across multiple cultures. However, some commercial ingenol mebutate products have been withdrawn due to safety concerns. Self-treatment with raw plant material carries significant risks including severe blistering and should only proceed under qualified medical supervision. Evidence Level: C.

Euphorbia peplus

Sources et citations

Résumé

Contexte

Usages traditionnels

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Synthèse des preuves

Sources PubMed

Sources gouvernementales